PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Kahn Sagol Maccabi Research and Innovation Center, Maccabi Healthcare Services, Tel Aviv, Israel.\', \'Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel.\', \'Public Health Modeling Unit, Yale School of Public Health, Yale University, New Haven, Connecticut.\', \'Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, Connecticut.\', \'Department of Biostatistics, Yale School of Public Health, Yale University, New Haven, Connecticut.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1001/jamainternmed.2021.7382
?:hasPublicationType
?:journal
  • JAMA internal medicine
is ?:pmid of
?:pmid
?:pmid
  • 34846533
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 8.032
?:rankingScore_hIndex
  • 300
is ?:relation_isRelatedTo_publication of
?:title
  • Odds of Testing Positive for SARS-CoV-2 Following Receipt of 3 vs 2 Doses of the BNT162b2 mRNA Vaccine.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all